GERI-BP002-A, novel inhibitor of Acyl-CoA: Cholesterol acyltransferase produced by Aspergillus fumigatus F93

被引:12
|
作者
Kim, YK
Lee, HW
Son, KH
Kwon, BM
Jeong, TS
Lee, DH
Shin, J
Seo, YW
Kim, SU
Bok, SH
机构
[1] KIST,KOREA RES INST BIOSCI & BIOTECHNOL,BIOPROD RES GRP,TAEJON 305600,SOUTH KOREA
[2] KONKUK UNIV,DEPT MICROBIAL ENGN,SEOUL 133701,SOUTH KOREA
[3] KOREA OCEAN RES & DEV INST,MARINE NAT PROD CHEM LAB,ANSAN 425600,SOUTH KOREA
来源
JOURNAL OF ANTIBIOTICS | 1996年 / 49卷 / 01期
关键词
D O I
10.7164/antibiotics.49.31
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A new inhibitor of acyl-CoA: cholesterol acyltransferase (ACAT), designated GERI-BP002-A, was isolated from the culture broth of Aspergillus fnmigatus F93 by acetone extraction, EtOAc extraction, SiO2 column chromatography and reverse phase HPLC. Spectroscopic analyses of the compound identified bis (2-hydroxy-3-tert-butyl-5-methylphenyl) methane as the structure and its molecular weight and formula to be 340 and C23H32O2, respectively. GERI-BP002-A inhibited ACAT activity by 50% at the concentration of 50 mu M in an enzyme assay system using rat liver microsomes.
引用
收藏
页码:31 / 36
页数:6
相关论文
共 50 条
  • [21] Effect of SMP-500, a novel acyl-CoA:cholesterol acyltransferase inhibitor, on the cholesterol esterification and its hypocholesterolemic properties
    Ioriya, K
    Noguchi, T
    Muraoka, M
    Fujita, K
    Shimizu, H
    Ohashi, N
    PHARMACOLOGY, 2002, 65 (01) : 18 - 25
  • [22] Inhibitors of acyl-CoA:cholesterol acyltransferase: Novel trisubstituted ureas as hypocholesterolemic agents
    Purchase, TS
    Essenburg, AD
    Hamelehle, KL
    Hes, MS
    Holmes, A
    Krause, BR
    Stanfield, RL
    Trivedi, BK
    BIOORGANIC & MEDICINAL CHEMISTRY, 1997, 5 (04) : 739 - 747
  • [23] Pheophorbide a-methyl ester, acyl-coa: cholesterol acyltransferase inhibitor fromDiospyros kaki
    Mun-Chual Rho
    Mi Yeon Chung
    Hye Young Song
    Oh Eok Kwon
    Seung Woong Lee
    Jin Ah Baek
    Kyung Hee Jeune
    Koanhoi Kim
    Hyun Sun Lee
    Young Kook Kim
    Archives of Pharmacal Research, 2003, 26 : 716 - 718
  • [24] Plaque stabilization of the novel acyl-CoA:cholesterol acyltransferase inhibitor, K-10191, in apoE knockout mice
    Kobayashi, H
    Kawamine, K
    Yoshinaka, Y
    Shibuya, K
    Sato, F
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 161 - 161
  • [25] Direct effect of F12511, a systemic inhibitor of acyl-CoA cholesterol acyltransferase on bovine aortic enclothelial cells
    Zamorano-Leon, Jose J.
    Fernandez-Sanchez, Ruth
    Lopez Farre, Antonio J.
    Lapuente-Tiana, Lucia
    Alonso-Orgaz, Sergio
    Sacristan, Daniel
    Junquera, Didier
    Delhon, Andre
    Conesa, Antonio
    Mateos-Caceres, Petra J.
    Macaya, Carlos
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2006, 48 (03) : 128 - 134
  • [26] Acyl-CoA: Cholesterol acyltransferase inhibitory activity of ginseng sapogenins, produced from the ginseng saponins
    Kwon, BM
    Kim, MK
    Baek, NI
    Kim, DS
    Park, JD
    Kim, YK
    Lee, HK
    Kim, SI
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (10) : 1375 - 1378
  • [27] DISPOSITION OF A SILICON-CONTAINING AMIDE, AN INHIBITOR OF ACYL-COA - CHOLESTEROL ACYLTRANSFERASE, IN DOG AND RAT
    TSE, FLS
    JAFFE, JM
    BIOPHARMACEUTICS & DRUG DISPOSITION, 1987, 8 (05) : 437 - 448
  • [29] The acyl-CoA:Cholesterol acyltransferase inhibitor, avasimibe, effectively limits lipid storage in human macrophages
    Rodriguez, A
    Wee, SB
    Usher, DC
    CIRCULATION, 1999, 100 (18) : 613 - 613
  • [30] Pheophorbide A-methyl ester, Acyl-CoA:: Cholesterol acyltransferase inhibitor from Diospyros kaki
    Rho, MC
    Chung, MY
    Song, HY
    Kwon, OE
    Lee, SW
    Baek, JA
    Jeune, KH
    Kim, K
    Lee, HS
    Kim, YK
    ARCHIVES OF PHARMACAL RESEARCH, 2003, 26 (09) : 716 - 718